Literature DB >> 7608291

Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma.

P Chanson, G Schaison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608291     DOI: 10.1210/jcem.80.7.7608291

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  14 in total

Review 1.  Pituitary apoplexy and idiopathic thrombocytopenic purpura: a new case and review of the literature.

Authors:  J C Maïza; A Bennet; M Thorn-Kany; J Lagarrigue; Ph Caron
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

2.  Pituitary apoplexy: a rare complication of leuprolide therapy in prostate cancer treatment.

Authors:  Georges Tanios; Nicolas Andrews Mungo; Aaysha Kapila; Kailash Bajaj
Journal:  BMJ Case Rep       Date:  2017-07-14

3.  Pituitary apoplexy after leuprolide.

Authors:  Anu Davis; Shefali Goel; Michalis Picolos; Min Wang; Victor Lavis
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

4.  Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin releasing hormone agonist therapy for prostatic cancer.

Authors:  Y Reznik; F Chapon; N Lahlou; N Deboucher; J Mahoudeau
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

Review 5.  Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.

Authors:  Yannis Guerra; Evelyn Lacuesta; Francisco Marquez; P B Raksin; Manuel Utset; Leon Fogelfeld
Journal:  Pituitary       Date:  2010       Impact factor: 4.107

Review 6.  GnRH agonist-associated pituitary apoplexy: a case series and review of the literature.

Authors:  Francisco J Guarda; Xiaoling Yu; Philip J Saylor; Lisa B Nachtigall; Naila Shiraliyeva; Melanie S Haines; Michael Bradbury
Journal:  Pituitary       Date:  2021-04-09       Impact factor: 4.107

7.  Pituitary apoplexy.

Authors:  Salam Ranabir; Manash P Baruah
Journal:  Indian J Endocrinol Metab       Date:  2011-09

8.  Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment.

Authors:  Mariana Barbosa; Sílvia Paredes; Maria João Machado; Rui Almeida; Olinda Marques
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-06-04

9.  Pituitary apoplexy induced by Gonadotropin-releasing hormone agonists for treating prostate cancer-report of first Asian case.

Authors:  Tsung-Yi Huang; Jih-Pin Lin; Ann-Shung Lieu; Yi-Ting Chen; Hung-Sheng Chen; Mei-Yu Jang; Jung-Tsung Shen; Wen-Jeng Wu; Shu-Pin Huang; Yung-Shun Juan
Journal:  World J Surg Oncol       Date:  2013-10-02       Impact factor: 2.754

10.  Gonadotropin-releasing hormone agonist-induced pituitary apoplexy.

Authors:  Fergus Keane; Aoife M Egan; Patrick Navin; Francesca Brett; Michael C Dennedy
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.